Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer.
Denise Marie A FranciscoLiangliang ZhangYing JiangAdilene OlveraJavier AdachiEduardo Yepez GuevaraSamuel L AitkenKevin W GareyChristine B PetersonKim-Anh DoRyan DillonEngels N ObiRobert JenqPablo C OkhuysenPublished in: Infectious diseases and therapy (2022)
Use of metronidazole for non-CDI indications within 90 days prior to diagnosis and presence of toxin A/B in stools were associated with severe CDI. Findings provide valuable insights into risk factors for severe CDI in an underserved population with cancer that warrants further exploration.